In the Italian pharmaceutical industry, there were 7 M&A deals announced in Q2 2023, worth a total value of $53.9m, according to GlobalData’s Deals Database. The $37.7m acquisition of archimica by pi health sciences netherlands was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, M&A activity in Italy remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal volume increased by 40% in Q2 2023 versus the previous quarter and was 40% higher than in Q2 2022.
The top-ranked legal advisorss supporting these M&A deals in Italy Q2 2023 were BonelliErede; CMS Legal Services EEIG; CMS Legal Services EEIG - France with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.